TGM2 and celiac disease: In celiac disease, mucosal recovery generally follows anti-tTG titer normalization after GFD introduction; however, it has been shown that mucosal damage can persist long after serological remission and, in some cases, tTG-negativity can be present along non-responsive or frankly refractory disease [35].